These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Tana C; Umesaki Y; Imaoka A; Handa T; Kanazawa M; Fukudo S Neurogastroenterol Motil; 2010 May; 22(5):512-9, e114-5. PubMed ID: 19903265 [TBL] [Abstract][Full Text] [Related]
29. Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment. Jalanka J; Salonen A; Fuentes S; de Vos WM Gut Microbes; 2015; 6(6):364-9. PubMed ID: 26512631 [TBL] [Abstract][Full Text] [Related]
30. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092 [TBL] [Abstract][Full Text] [Related]
31. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome. Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430 [TBL] [Abstract][Full Text] [Related]
33. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575 [No Abstract] [Full Text] [Related]
34. Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome. Hollister EB; Oezguen N; Chumpitazi BP; Luna RA; Weidler EM; Rubio-Gonzales M; Dahdouli M; Cope JL; Mistretta TA; Raza S; Metcalf GA; Muzny DM; Gibbs RA; Petrosino JF; Heitkemper M; Savidge TC; Shulman RJ; Versalovic J J Mol Diagn; 2019 May; 21(3):449-461. PubMed ID: 31005411 [TBL] [Abstract][Full Text] [Related]
35. Gut microbiota as potential orchestrators of irritable bowel syndrome. Bennet SM; Ohman L; Simren M Gut Liver; 2015 May; 9(3):318-31. PubMed ID: 25918261 [TBL] [Abstract][Full Text] [Related]
36. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients. Zhou XY; Li M; Li X; Long X; Zuo XL; Hou XH; Cong YZ; Li YQ World J Gastroenterol; 2016 Jun; 22(22):5211-27. PubMed ID: 27298564 [TBL] [Abstract][Full Text] [Related]
37. Treating irritable bowel syndrome with probiotics: the evidence. Parkes GC; Sanderson JD; Whelan K Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566 [TBL] [Abstract][Full Text] [Related]
38. The Intestinal Microbiota and Irritable Bowel Syndrome. Ringel Y; Ringel-Kulka T J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966 [TBL] [Abstract][Full Text] [Related]
40. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]